Your browser doesn't support javascript.
loading
Unveiling the HER2-low phenomenon: exploring immunohistochemistry and gene expression to characterise HR-positive HER2-negative early breast cancer.
Gaudio, M; Jacobs, F; Benvenuti, C; Saltalamacchia, G; Gerosa, R; De Sanctis, R; Santoro, A; Zambelli, A.
Afiliação
  • Gaudio M; Department of Biomedical Sciences, Humanitas University, 20072, Pieve Emanuele, MI, Italy.
  • Jacobs F; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, 20089, Rozzano, MI, Italy.
  • Benvenuti C; Department of Biomedical Sciences, Humanitas University, 20072, Pieve Emanuele, MI, Italy.
  • Saltalamacchia G; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, 20089, Rozzano, MI, Italy.
  • Gerosa R; Department of Biomedical Sciences, Humanitas University, 20072, Pieve Emanuele, MI, Italy.
  • De Sanctis R; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, 20089, Rozzano, MI, Italy.
  • Santoro A; Department of Biomedical Sciences, Humanitas University, 20072, Pieve Emanuele, MI, Italy.
  • Zambelli A; Department of Biomedical Sciences, Humanitas University, 20072, Pieve Emanuele, MI, Italy.
Breast Cancer Res Treat ; 203(3): 487-495, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37923964

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article